Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The cyclin-dependent kinase inhibitor p16INK4a can induce senescence of human cells, and its loss by deletion, mutation or epigenetic silencing is among the most frequently observed molecular lesions in human cancer. Overlapping reading frames in the INK4A/ARF gene encode p16INK4a and a distinct tumour-suppressor protein, p19ARF (ref. 3). Here we describe the generation and characterization of a p16Ink4a-specific knockout mouse that retains normal p19Arf function. Mice lacking p16Ink4a were born with the expected mendelian distribution and exhibited normal development except for thymic hyperplasia. T cells deficient in p16Ink4a exhibited enhanced mitogenic responsiveness, consistent with the established role of p16Ink4a in constraining cellular proliferation. In contrast to mouse embryo fibroblasts (MEFs) deficient in p19Arf (ref. 4), p16Ink4a-null MEFs possessed normal growth characteristics and remained susceptible to Ras-induced senescence. Compared with wild-type MEFs, p16Ink4a-null MEFs exhibited an increased rate of immortalization, although this rate was less than that observed previously for cells null for Ink4a/Arf, p19Arf or p53 (refs 4, 5). Furthermore, p16Ink4a deficiency was associated with an increased incidence of spontaneous and carcinogen-induced cancers. These data establish that p16Ink4a, along with p19Arf, functions as a tumour suppressor in mice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p19 Arf and, to a lesser extent, p16 Ink4a have been shown to play a role in the activation of cellular senescence and immortalization on passaging of primary mouse cells in culture (26, 43, 44).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [43]
In the citing paper
“In vivo (mouse model) studies indicate that p16 suppresses the development of spontaneous cancer (Sharpless et al., 2001).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Sharpless et al., 2001
In the citing paper
“Mutations in p16 , Rb , ARF and TP53 are frequently found in human cancers, and their tumour-suppressive roles have been confirmed in vivo using genetically modified mouse models [25 -29].”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [29]
In the citing paper
“Mutations in p16 , Rb , ARF and TP53 are frequently found in human cancers, and their tumour-suppressive roles have been confirmed in vivo using genetically modified mouse models [25 -29].”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [29]
In the citing paper
“Real-time methylation-specific PCR (MSR) was used to detect the methylation of CpG islands flanking the translation start site of murine p16Ink4a 28,29, revealing a significant increase in methylated CpG sites at the promoter region of p16Ink4a in middle-aged mouse tissues after TAC treatment compared with vehicle controls (Figure 3H).”
From TERT activation targets DNA methylation and multiple aging hallmarks (2024) · cites this paper as [28]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“exhibit more rapid growth rates and are more readily immortalized in culture, are susceptible to transformation by activated H-Ras alone, and exhibit resistance to Ras-induced senescenc”
BackgroundRole of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Self-citationTumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Ouelle, D. E., Zindy, F., Ashmun, R. A., & Sherr, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90214-7 · Cited by 1,485
Herman, J. G., Merlo, A. U., Mao, L., Lapidus, R. G., Issa, J. J., Davidson, N. E., Sidransky, D., & Baylin, S. B. (1995) · PubMed · Cited by 1,341
Efficient in vivo manipulation of mouse genomic sequences at the zygote stage.
Lakso, M., Pichel, J. G., Gorman, J. R., Sauer, B., Okamoto, Y., Lee, E., Alt, F. W., & Westphal, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5860 · Cited by 1,125 · cited 1×
“Mice heterozygous for this mutant allele were crossed with EIIa-Cre mic”
MethodD-type cyclin-dependent kinase activity in mammalian cells.
Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., & Kato, J. Y. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2066 · Cited by 1,064
Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., & Barrett, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13742 · Cited by 1,008 · cited 1×
“Accumulation of p16 INK4a correlates with the onset of senescence in human cell”
Background
Cited by
Items 201–300 of 850
TERT activation targets DNA methylation and multiple aging hallmarks
Shim, H. S., Iaconelli, J., Shang, X., Li, J., Lan, Z. D., Jiang, S., Nutsch, K., Beyer, B. A., Lairson, L. L., Boutin, A. T., et al. (2024) · Cell · doi:10.1016/j.cell.2024.05.048 · Cited by 104
Self-citationCyclin D–Cdk4 is regulated by GATA-1 and required for megakaryocyte growth and polyploidization
Muntean, A. G., Pang, L., Poncz, M., Dowdy, S. F., Blobel, G. A., & Crispino, J. D. (2007) · Blood · doi:10.1182/blood-2006-11-059378 · Cited by 115
Petrenko, O., Zaika, A. I., & Moll, U. M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5540-5555.2003 · Cited by 123
Chemotherapy-induced senescence, an adaptive mechanism driving resistance and tumor heterogeneity
Guillon, J., Petit, C., Toutain, B., Guette, C., Lelièvre, E., & Coqueret, O. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1652047 · Cited by 102
“[7] Sharpless NE, Bardeesy N, Lee KH, et al.”
BackgroundSigner, R. A. J., Montecino-Rodriguez, E., Witte, O. N., & Dorshkind, K. (2008) · Genes & Development · doi:10.1101/gad.1715808 · Cited by 102
p53-Dependent and -Independent Functions of the Arf Tumor Suppressor
SHERR, C. J., BERTWISTLE, D., DEN BESTEN, W., KUO, M.-L., SUGIMOTO, M., TAGO, K., WILLIAMS, R. T., ZINDY, F., & ROUSSEL, M. F. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.004 · Cited by 101
Berggren, P., Kumar, R., Sakano, S., Hemminki, L., Wada, T., Steineck, G., Adolfsson, J., Larsson, P., Norming, U., Wijkström, H., et al. (2003) · PubMed · Cited by 114
Novais, E. J., Diekman, B. O., Shapiro, I. M., & Risbud, M. V. (2019) · Matrix Biology · doi:10.1016/j.matbio.2019.02.004 · Cited by 100
Haploinsufficiency of p18INK4c Sensitizes Mice to Carcinogen-Induced Tumorigenesis
Bai, F., Pei, X.-H., Godfrey, V. L., & Xiong, Y. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.4.1269-1277.2003 · Cited by 100
Qiu, W., Sahin, F., Iacobuzio-Donahue, C. A., Garcia-Carracedo, D., Wang, W. M., Kuo, C.-Y., Chen, D., Arking, D. E., Lowy, A. M., Hruban, R. H., et al. (2011) · Oncotarget · doi:10.18632/oncotarget.357 · Cited by 99
“p16-/- mice (which retain p19/ARF) spontaneously develop and die from a variety of malignant tumors, including soft-tissue sarcoma, lymphoma, and melanoma [22], so the potential tumorigenic effects of p16 loss in the pancreas are not known.”
Ink4‐Arf locus in cancer and aging
Sherr, C. J. (2012) · WIREs Developmental Biology · doi:10.1002/wdev.40 · Cited by 98
Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo
Sharpless, N. E., Kannan, K., Xu, J., Bosenberg, M., & Chin, L. (2003) · Oncogene · doi:10.1038/sj.onc.1206809 · Cited by 116
Self-citationWatanabe, M., Moon, K. D., Vacchio, M. S., Hathcock, K. S., & Hodes, R. J. (2014) · Immunity · doi:10.1016/j.immuni.2014.04.006 · Cited by 97
The role of p53 in pigmentation, tanning and melanoma
Box, N. F., & Terzian, T. (2008) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2008.00495.x · Cited by 96
Molecular Regulation of Melanocyte Senescence
Bennett, D. C., & Medrano, E. E. (2002) · Pigment Cell Research · doi:10.1034/j.1600-0749.2002.02036.x · Cited by 95
Aghi, M. K., Visted, T., DePinho, R. A., & Chiocca, E. A. (2008) · Oncogene · doi:10.1038/onc.2008.53 · Cited by 94
Self-citationActivated BRAF induces gliomas in mice when combined with Ink4a/Arf loss or Akt activation
Robinson, J. P., VanBrocklin, M. W., Guilbeault, A. R., Signorelli, D. L., Brandner, S., & Holmen, S. L. (2009) · Oncogene · doi:10.1038/onc.2009.333 · Cited by 99
The significance of telomerase activation and cellular immortalization in human cancer
Newbold, R. F. (2002) · Mutagenesis · doi:10.1093/mutage/17.6.539 · Cited by 100
Drayton, S., Rowe, J., Jones, R., Vatcheva, R., Heavens, D., Marshall, J. F., Fried, M., & Peters, G. G. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00242-3 · Cited by 98
Control of cellular senescence by CPEB
Groisman, I., Ivshina, M., Marin, V., Kennedy, N. J., Davis, R. J., & Richter, J. D. (2006) · Genes & Development · doi:10.1101/gad.1438906 · Cited by 94
A Melanoma Molecular Disease Model
Vidwans, S. J., Flaherty, K. T., Fisher, D. E., Tenenbaum, J. M., Travers, M., & Shrager, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018257 · Cited by 106
Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma
Tchougounova, E., Kastemar, M., Bråsäter, D., Holland, E. C., Westermark, B., & Uhrbom, L. (2007) · Oncogene · doi:10.1038/sj.onc.1210455 · Cited by 94
Taniai, M., Higuchi, H., Burgart, L. J., & Gores, G. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36021 · Cited by 99
Does vitamin D protect against DNA damage?
Nair-Shalliker, V., Armstrong, B. K., & Fenech, M. (2012) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2012.02.005 · Cited by 92
Ink4a/arf deficiency promotes ultraviolet radiation-induced melanomagenesis.
Recio, J. A., Noonan, F. P., Takayama, H., Anver, M. R., Duray, P. H., Rush, W. L., Lindner, G., Fabo, E. C. D., DePinho, R. A., & Merlino, G. T. (2002) · PubMed · Cited by 117
Self-citationThe MTAP-CDKN2A Locus Confers Susceptibility to a Naturally Occurring Canine Cancer
Shearin, A. L., Hédan, B., Cadieu, É., Erich, S. A., Schmidt, E. V., Faden, D. L., Cullen, J. M., Abadie, J., Kwon, E. M., Gröne, A., et al. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0190-t · Cited by 104
Tang, Y., Xu, J., Qu, W., Peng, X., Peng, X., Yang, X., Ying, C., Sun, X., & Hao, L. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.08.008 · Cited by 93
Transforming growth factor-β pathway: Role in pancreas development and pancreatic disease
Rane, S. G., Lee, J., & LIN, H. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.003 · Cited by 98
Both Ends of the Leash — The Human Links to Good Dogs with Bad Genes
Ostrander, E. A. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1204453 · Cited by 101
Targeted p16Ink4a epimutation causes tumorigenesis and reduces survival in mice
Yu, D.-H., Waterland, R. A., Zhang, P., Schady, D. A., Chen, M.-H., Guan, Y., Gadkari, M., & Shen, L. (2014) · Journal of Clinical Investigation · doi:10.1172/jci76507 · Cited by 93
Wei, W., Herbig, U., Wei, S., Dutriaux, A., & Sedivy, J. M. (2003) · The EMBO Reports · doi:10.1038/sj.embor.7400001 · Cited by 88
“Although p16 is induced in senescent MEFs, it apparently has a minor role, and p16 knockout MEFs do not immortalize with increased frequency (Sharpless et al., 2001).”
Bertin, R., Acquaviva, C., Mirebeau‐Prunier, D., Guidal, C., VILMER, E., & Cavé, H. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10188 · Cited by 97
p16INK4A Represses the paracrine tumor-promoting effects of breast stromal fibroblasts
Al‐Ansari, M. M., Hendrayani, S., Shehata, A. I., & Aboussekhra, A. (2012) · Oncogene · doi:10.1038/onc.2012.270 · Cited by 92
Cell-specific responses to loss of cyclin-dependent kinases
Berthet, C., & Kaldis, P. (2007) · Oncogene · doi:10.1038/sj.onc.1210243 · Cited by 97
Cudré-Mauroux, C., Occhiodoro, T., König, S., Salmon, P., Bernheim, L., & Trono, D. (2003) · Human Gene Therapy · doi:10.1089/104303403322495034 · Cited by 87
Cutaneous melanoma in genetically modified animals
Larue, L., & Beermann, F. (2007) · Pigment Cell Research · doi:10.1111/j.1600-0749.2007.00411.x · Cited by 107
Zhang, S., Qian, X., Redman, C., Bliskovski, V., Ramsay, E. S., Lowy, D. R., & Mock, B. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206257 · Cited by 92
Replicative senescence revisited.
Marcotte, R., & Wang, E. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.7.b257 · Cited by 86
Prevalence of aberrant methylation of p14ARF over p16INK4a in some human primary tumors
Domínguez, G., Silva, J., Garcia, J. M., Silva, J. M., Rodríguez, R., Muñoz, C., Chacón, I., Sanchez, R., Carballido, J., Colás, A., et al. (2003) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(03)00133-7 · Cited by 98
Kranc, K. R., Bamforth, S. D., Bragança, J., Norbury, C., van Lohuizen, M., & Bhattacharya, S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7658-7666.2003 · Cited by 86
Genetic and Epigenetic Changes in Mammary Epithelial Cells May Mimic Early Events in Carcinogenesis
Tlsty, T. D., Crawford, Y., Holst, C. R., Fordyce, C., Zhang, J., McDermott, K. M., Kozakiewicz, K., & Gauthier, M. L. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000048773.95897.5f · Cited by 89
Ageing as developmental decay: insights from p16INK4a.
Martin, N., Beach, D., & Gil, J. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.09.008 · Cited by 76
Role of the RB Tumor Suppressor in Cancer
Yamasaki, L. (2006) · Cancer Treatment and Research · doi:10.1007/0-306-48158-8_9 · Cited by 84
Oncogene activation in melanocytes links reactive oxygen to multinucleated phenotype and senescence
Leikam, C., Hufnagel, A., Schartl, M., & Meierjohann, S. (2008) · Oncogene · doi:10.1038/onc.2008.323 · Cited by 94
The p16INK4a tumor suppressor controls p21WAF1 induction in response to ultraviolet light
Almohanna, M., Al‐Khalaf, H. H., Al‐Yousef, N., & Aboussekhra, A. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl1075 · Cited by 92
Distinct E2F‐mediated transcriptional program regulates p14 ARF gene expression
Komori, H., Enomoto, M., Nakamura, M., Iwanaga, R., & Ohtani, K. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600836 · Cited by 97
Vidal, A., Millard, S. S., Miller, J. P., & Koff, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112090200 · Cited by 83
LKB1 Deficiency Sensitizes Mice to Carcinogen-Induced Tumorigenesis
Gurumurthy, S., Hezel, A. F., Berger, J. H., Bosenberg, M. W., & Bardeesy, N. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3225 · Cited by 82
Self-citationGrillo, M., Bott, M. J., Khandke, N., McGinnis, J. P., Miranda, M., Meyyappan, M., Rosfjord, E. C., & Rabindran, S. K. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9066-y · Cited by 89
Tanaka, T. U., Akatsuka, S., Ozeki, M., Shirase, T., Hiai, H., & Toyokuni, S. (2004) · Oncogene · doi:10.1038/sj.onc.1207555 · Cited by 85
Kanellou, P., Zaravinos, A., Zioga, M., Stratigos, A., Baritaki, S., Soufla, G., Zoras, O., & Spandidos, D. A. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.01.042 · Cited by 90
Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts
Lindström, M. S., & Wiman, K. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206659 · Cited by 94
Mühleder, S., Fernández-Chacón, M., García-Gónzalez, I., & Benedito, R. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03664-y · Cited by 89
Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction
Suda, M., Paul, K. H., Tripathi, U., Minamino, T., Tchkonia, T., & Kirkland, J. L. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae010 · Cited by 99
Building ‘validated’ mouse models of human cancer
Hann, B. C., & Balmain, A. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00283-0 · Cited by 91
Rare codons capacitate Kras-driven de novo tumorigenesis
Pershing, N. L. K., Lampson, B. L., Belsky, J. A., Kaltenbrun, E., MacAlpine, D. M., & Counter, C. M. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77627 · Cited by 77
Research models and mesenchymal/epithelial plasticity of osteosarcoma
Yu, X., Yustein, J. T., & Xu, J. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00600-w · Cited by 81
Ablation of the p16INK4a tumour suppressor reverses ageing phenotypes of klotho mice
Sato, S., Kawamata, Y., Takahashi, A., Imai, Y., Hanyu, A., Okuma, A., Takasugi, M., Yamakoshi, K., Sorimachi, H., Kanda, H., et al. (2015) · Nature Communications · doi:10.1038/ncomms8035 · Cited by 77
New roles for cyclin-dependent kinases in T cell biology: linking cell division and differentiation
Wells, A. D., & Morawski, P. A. (2014) · Nature Reviews Immunology · doi:10.1038/nri3625 · Cited by 76
Ras-Induced Senescence and its Physiological Relevance in Cancer
DiMauro, T., & David, G. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910793357998 · Cited by 76
Milyavsky, M., Shats, I., Cholostoy, A., Brosh, R., Buganim, Y., Weisz, L., Kogan, I., Cohen, M., Shatz, M., Madar, S., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.022 · Cited by 79
Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets
Maharjan, C. K., Ear, P. H., Tran, C. G., Howe, J. R., Chandrasekharan, C., & Quelle, D. E. (2021) · Cancers · doi:10.3390/cancers13205117 · Cited by 76
Biology of MET: a double life between normal tissue repair and tumor progression.
Petrini, I. (2015) · PubMed Central · doi:10.3978/j.issn.2305-5839.2015.03.58 · Cited by 75
Guijarro, M. V., Ghivizzani, S. C., & Gibbs, C. P. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00189 · Cited by 73
Obligate Roles for p16Ink4a and p19Arf-p53 in the Suppression of Murine Pancreatic Neoplasia
Bardeesy, N., Morgan, J., Sinha, M., Signoretti, S., Srivastava, S., Loda, M., Merlino, G., & DePinho, R. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.2.635-643.2002 · Cited by 74
Self-citationWilliams, T. M., Lee, H., Cheung, M. W.-C., Cohen, A. W., Razani, B., Iyengar, P., Scherer, P. E., Pestell, R. G., & Lisanti, M. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402064200 · Cited by 88
Cross‐species models of human melanoma
van der Weyden, L., Patton, E. E., Wood, G. A., Foote, A. K., Brenn, T., Arends, M. J., & Adams, D. J. (2015) · The Journal of Pathology · doi:10.1002/path.4632 · Cited by 84
Wikman, H., & Kettunen, E. (2006) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.6.4.515 · Cited by 72
Cellular Senescence: Mechanisms, Morphology, and Mouse Models
Beck, J. A., Horikawa, I., & Harris, C. C. (2020) · Veterinary Pathology · doi:10.1177/0300985820943841 · Cited by 87
p53 Protein and Pathogenesis of Melanoma and Nonmelanoma Skin Cancer
Benjamin, C. L., Melnikova, V. O., & Ananthaswamy, H. N. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-77574-6_21 · Cited by 84
Cyclin D1 Activity Regulates Autophagy and Senescence in the Mammary Epithelium
Brown, N. E., Jeselsohn, R., Bihani, T., Hu, M. G., Foltopoulou, P., Kuperwasser, C., & Hinds, P. W. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4139 · Cited by 72
Pathways to Melanoma Development: Lessons from the Mouse
Walker, G. J., & Hayward, N. K. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.00217.x · Cited by 83
Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward
Khan, M. A., Azim, S., Zubair, H., Bhardwaj, A., Patel, G. K., Khushman, M. M., Singh, S., & Singh, A. P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040779 · Cited by 82
Endothelial Senescence: A New Age in Pulmonary Hypertension
Culley, M. K., & Chan, S. Y. (2022) · Circulation Research · doi:10.1161/circresaha.121.319815 · Cited by 75
Dlugosz, A. A., Merlino, G. T., & Yuspa, S. H. (2002) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1523-1747.2002.19631.x · Cited by 81
Carrasco, D. R., Fenton, T. R., Sukhdeo, K., Protopopova, M., Enos, M., You, M. J., Divicio, D., Nogueira, C., Stommel, J. M., Pinkus, G. S., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.028 · Cited by 75
Self-citationIntegrating Physiological Regulation with Stem Cell and Tissue Homeostasis
Nakada, D., Levi, B. P., & Morrison, S. J. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.011 · Cited by 86
The Role of p16INK4a Pathway in Human Epidermal Stem Cell Self-Renewal, Aging and Cancer
D’Arcangelo, D., Tinaburri, L., & Dellambra, E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071591 · Cited by 85
Okuma, A., Hanyu, A., Watanabe, S., & Hara, E. (2017) · Nature Communications · doi:10.1038/s41467-017-02281-x · Cited by 69
Role of Epidermal Growth Factor Receptor Signaling in RAS-Driven Melanoma
Bardeesy, N. M., Kim, M., Xu, J., Kim, R.-S., Shen, Q. “., Bosenberg, M., Wong, W. H., & Chin, L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.10.4176-4188.2005 · Cited by 81
Self-citationDDB1-CUL4 and MLL1 Mediate Oncogene-Induced p16 INK4a Activation
Kotake, Y., Zeng, Y., & Xiong, Y. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2739 · Cited by 69
Rescue of key features of the p63‐null epithelial phenotype by inactivation of Ink4a and Arf
Su, X., Cho, M. S., Gi, Y. J., Ayanga, B. A., Sherr, C. J., & Flores, E. R. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.151 · Cited by 78
Markers of cellular senescence.
Carnero, A. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_4 · Cited by 68
Stepanova, L., & Sorrentino, B. P. (2005) · Blood · doi:10.1182/blood-2004-06-2242 · Cited by 68
Xia, Y., Liu, Y., Yang, C., Simeone, D. M., Sun, T., DeGraff, D. J., Tang, M.-S., Zhang, Y., & Wu, X. (2021) · Nature Communications · doi:10.1038/s41467-021-22327-5 · Cited by 77
Almohanna, M., Manogaran, P. S., AL‐MUKHALAFI, Z., Al‐Hussein, K., & Aboussekhra, A. (2004) · Oncogene · doi:10.1038/sj.onc.1206927 · Cited by 81
Investigation of the Possible Role of a Novel Gene, DPCD , in Primary Ciliary Dyskinesia
Zariwala, M. A., O’Neal, W. K., Noone, P. G., Leigh, M. W., Knowles, M. R., & Ostrowski, L. E. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0338rc · Cited by 68
Smeds, J., Berggren, P., Ma, X., Xu, Z., Hemminki, K., & Kumar, R. (2002) · Carcinogenesis · doi:10.1093/carcin/23.4.645 · Cited by 71
Yang, D., McCrann, D. J., Nguyen, H., Hilaire, C. S., DePinho, R. A., Jones, M. R., & Ravid, K. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00274.x · Cited by 67
Self-citationSharp, T. V., Al‐Attar, A., Foxler, D. E., Ding, L., Vallim, T. Q. D. A., Zhang, Y., Nijmeh, H., Webb, T. M., Nicholson, A. G., Zhang, Q., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805003105 · Cited by 76
Genes and pathways driving glioblastomas in humans and murine disease models
Merlo, A. (2003) · Neurosurgical Review · doi:10.1007/s10143-003-0267-8 · Cited by 75
Altomare, D. A., Menges, C. W., Xu, J., Pei, J., Zhang, L., Tadevosyan, A., Neumann-Domer, E., Liu, Z., Carbone, M., Chudoba, I., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018828 · Cited by 65
Molecular genetics of neuroendocrine tumors
Duerr, E., & Chung, D. C. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.12.001 · Cited by 70
Ruple, A., MacLean, E. L., Snyder‐Mackler, N., Creevy, K. E., & Promislow, D. (2021) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-051021-080937 · Cited by 81
Haploinsufficient tumor suppressor genes.
Inoue, K., & Fry, E. A. (2017) · PubMed · Cited by 85
Jirawatnotai, S., Moons, D. S., Stocco, C. O., Franks, R. R., Hales, D. B., Gibori, G., & Kiyokawa, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301206200 · Cited by 69
Finnberg, N. K., Wambi, C. O., Ware, J. H., Kennedy, A. R., & El‐Deiry, W. S. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.12.7417 · Cited by 62
p16(INK4a) and p53 deficiency cooperate in tumorigenesis.
Sharpless, N. E., Alson, S., Chan, S., Silver, D. P., Castrillón, D. H., & DePinho, R. A. (2002) · PubMed · Cited by 83
Self-citationLoss of p16 expression is associated with histological features of melanoma invasion
Pavey, S. J., Cummings, M. C., Whiteman, D. C., Castellano, M., Walsh, M. D., Gabrielli, B. G., Green, A. C., & Hayward, N. K. (2002) · Melanoma Research · doi:10.1097/00008390-200212000-00003 · Cited by 66
Simin, K., Wu, H., Lu, L., Pinkel, D., Albertson, D., Cardiff, R. D., & Dyke, T. V. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020022 · Cited by 62
Metadata
- Authors
- Sharpless, N. E., Bardeesy, N., Lee, K.-H., Carrasco, D., Castrillon, D. H., Aguirre, A. J., Wu, E. A., Horner, J. W., & DePinho, R. A.
- Affiliations
- Harvard University (US)
- Corresponding author
- DePinho, Ronald A.
- Venue
- Nature
- Published
- 2001-09
- Volume
- 413
- Issue
- 6851
- Pages
- 86-91
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2017235640
- Cited by
- 848
- References
- 30
- Citations by year
- 2026: 7 · 2025: 2 · 2024: 19 · 2023: 26 · 2022: 15 · 2021: 36 · 2020: 17 · 2019: 17 · 2018: 17 · 2017: 26 · 2016: 17 · 2015: 29 · 2014: 32 · 2013: 34 · 2012: 34
- FWCI
- 29.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- KWF Kankerbestrijding
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- p16INK4a, p19ARF, tumour suppressor, senescence, carcinogenesis, knockout mice, thymic hyperplasia, T cell proliferation, Ras-induced senescence, cell immortalization, carcinogen-induced cancer, p53
- MeSH terms
- Animals, Carcinogens, Cell Division, Cell Transformation, Neoplastic, Cells, Cultured, Embryo, Mammalian, Female, Fibroblasts, Male, Neoplasms, Proteins, T-Lymphocytes, Thymus Gland, Urethane, 9,10-Dimethyl-1,2-benzanthracene, Gene Deletion, Mice, Knockout, Gene Targeting, Genes, p16, Genetic Predisposition to Disease, Tumor Suppressor Protein p14ARF, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.